Brickell Biotech Raises $7M Series B
Brickell Biotech Inc., a development-stage pharmaceutical company focused on treating skin diseases, has raised $7 million in Series B financing. The round was led by AMOREPACIFIC Ventures, part of the Korean cosmetic company AMOREPACIFIC. Other investors include Palisade Concentrated Equity Partnership II, L.P., a private equity fund managed by Palisade Capital Management.
26 February 2013•4 mins read
